IDA total vs Malawi: Access to anti-retroviral drugs, male
IDA total
78.2%
in 2024
Malawi
90.0%
in 2024
IDA total rank
11th
Malawi rank
13th
Access to anti-retroviral drugs, male over time
- IDA total
- Malawi
How they compare
Malawi currently reports 90.0% against 78.2% in IDA total, a difference of 11.8%.
That makes Malawi's figure about 1.2 times IDA total's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Malawi ahead.
IDA total ranks 11th and Malawi ranks 13th of 19 groups.
Malawi has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA total | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.6% | 6.3% | 0.7% | Malawi |
| 2010s | 39.4% | 55.4% | 16.0% | Malawi |
| 2020s | 71.1% | 86.8% | 15.7% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, IDA total or Malawi?
- Malawi, at 90.0% against 78.2% in IDA total as of 2024.
- What is the difference in access to anti-retroviral drugs, male between IDA total and Malawi?
- 11.8%, with Malawi ahead.
- How many years of comparable data are there for IDA total and Malawi?
- 25 years are reported by both, from 2000 to 2024.
- How do IDA total and Malawi rank globally for access to anti-retroviral drugs, male?
- IDA total ranks 11th and Malawi ranks 13th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.